Mutation of the CBP gene has been detected in approximately 50% of affected individuals with RSTS. Mutations in EP300 on 22q13.2 account for a small number of cases. Epigenetic alterations have been suggested as a possible cause for the remaining cases, as approximately 50% of individuals with clinical features consistent with RSTS do not have detectable deletion or mutation in CBP or EP300.